IVWAX Fees and Costs — IVA Worldwide Fund, Class A
Data updated: 2021-05-24
The net expense ratio is 1.20%: a 0.80% management fee, a 0.25% 12b-1 fee plus 0.14% other expenses. This share class carries a maximum front-end sales load of 5.00%, a deferred sales charge of up to 0.75% and a redemption fee of 2.00%. In fiscal 2020 the fund paid $1.9M in broker commissions, 0.0443% of average net assets, and portfolio turnover was 49%.
IVWAX Fees and Expenses
Annual operating expenses and sales charges of IVWAX. Prospectus, as of January 31, 2021.
| Annual operating expenses | |
|---|---|
| Management fee | 0.80% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.14% |
| Gross expense ratio | 1.20% |
| Fee waiver | — |
| Net expense ratio | 1.20% |
| Sales charges | |
|---|---|
| Max front load | 5.00% |
| Max deferred load | 0.75% |
| Redemption fee | 2.00% |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
IVWAX Costs Over Time
On $10,000 invested in IVWAX, assuming 5% a year before costs, total costs come to $1,374 over 5 years, cutting the return by 2.36% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $574 | $500 | $500 |
| Fund expenses (net expense ratio 1.20%) | $120 | $373 | $644 |
| Trading costs (broker commissions) | $4 | $14 | $24 |
| Lost growth on money paid in costs | $25 | $98 | $206 |
| Total costs | $723 | $984 | $1,374 |
| Value after costs | $9,777 | $10,592 | $11,389 |
| Impact on return, per year | 7.23% | 3.06% | 2.36% |
IVWAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2020.
- Explicit cost rate (commissions ÷ average net assets): 0.0443%
- Total broker commissions: $1.9M
- Bought from dealers (principal trades, not a cost): $41.8B
- Portfolio turnover (prospectus): 49%
- Securities lending: none during the year
IVWAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Sanford C. Bernstein & Co., LLC | $359K | 23.62% |
| UBS Securities LLC | $201K | 13.20% |
| Redburn (USA) LLC | $183K | 12.06% |
| Societe Generale | $146K | 9.59% |
| Bofa Securities, Inc. | $131K | 8.62% |
| J.P. Morgan Securities LLC | $122K | 8.06% |
| CITIC Securities International USA, LLC | $122K | 8.03% |
| Barclays Capital Inc. | $112K | 7.35% |
| HSBC Securities (USA) Inc. | $78K | 5.14% |
| Exane, Inc. | $66K | 4.33% |
IVWAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Bofa Securities, Inc. | $13.4B | 32.13% |
| Goldman Sachs & Co. LLC | $9.3B | 22.25% |
| Citigroup Global Markets Inc. | $7.8B | 18.59% |
| State Street Bank and Trust Company | $7.7B | 18.51% |
| J.P. Morgan Securities LLC | $3.1B | 7.50% |
| HSBC Securities (USA) Inc. | $222.1M | 0.53% |
| RBC Capital Markets, LLC | $99.9M | 0.24% |
| Credit Suisse Securities (USA) LLC | $96.6M | 0.23% |
| Morgan Stanley & Co. LLC | $5.7M | 0.01% |
| R.W.Pressprich & Co. | $2.1M | 0.01% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.